496 related articles for article (PubMed ID: 19903491)
21. Cystic fibrosis and the use of pharmacogenomics to determine surrogate endpoints for drug discovery.
Eidelman O; Zhang J; Srivastava M; Pollard HB
Am J Pharmacogenomics; 2001; 1(3):223-38. PubMed ID: 12083969
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators.
Perrem L; Ratjen F
Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S46-S55. PubMed ID: 31715088
[TBL] [Abstract][Full Text] [Related]
23. [Evidence-based treatment of cystic fibrosis].
Ringshausen FC; Hellmuth T; Dittrich AM
Internist (Berl); 2020 Dec; 61(12):1212-1229. PubMed ID: 33201261
[TBL] [Abstract][Full Text] [Related]
24. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
[TBL] [Abstract][Full Text] [Related]
25. Cystic fibrosis.
Elborn JS
Lancet; 2016 Nov; 388(10059):2519-2531. PubMed ID: 27140670
[TBL] [Abstract][Full Text] [Related]
26. Role of CFTR in airway disease.
Pilewski JM; Frizzell RA
Physiol Rev; 1999 Jan; 79(1 Suppl):S215-55. PubMed ID: 9922383
[TBL] [Abstract][Full Text] [Related]
27. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.
Kwilas AR; Yednak MA; Zhang L; Liesman R; Collins PL; Pickles RJ; Peeples ME
J Virol; 2010 Aug; 84(15):7770-81. PubMed ID: 20504917
[TBL] [Abstract][Full Text] [Related]
28. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
29. CFTR: cystic fibrosis and beyond.
Mall MA; Hartl D
Eur Respir J; 2014 Oct; 44(4):1042-54. PubMed ID: 24925916
[TBL] [Abstract][Full Text] [Related]
30. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
Kuk K; Taylor-Cousar JL
Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
[TBL] [Abstract][Full Text] [Related]
31. Modulation of Ion Transport to Restore Airway Hydration in Cystic Fibrosis.
Reihill JA; Douglas LEJ; Martin SL
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33810137
[TBL] [Abstract][Full Text] [Related]
32. New treatments targeting the basic defects in cystic fibrosis.
Fajac I; Wainwright CE
Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
[TBL] [Abstract][Full Text] [Related]
33. Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning.
Barry PJ; Ronan N; Plant BJ
Semin Respir Crit Care Med; 2015 Apr; 36(2):287-98. PubMed ID: 25826594
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics of cystic fibrosis treatment.
Carter SC; McKone EF
Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
[TBL] [Abstract][Full Text] [Related]
35. Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.
Solomon GM; Marshall SG; Ramsey BW; Rowe SM
Pediatr Pulmonol; 2015 Oct; 50 Suppl 40(0 40):S3-S13. PubMed ID: 26097168
[TBL] [Abstract][Full Text] [Related]
36. miR-16 rescues F508del-CFTR function in native cystic fibrosis epithelial cells.
Kumar P; Bhattacharyya S; Peters KW; Glover ML; Sen A; Cox RT; Kundu S; Caohuy H; Frizzell RA; Pollard HB; Biswas R
Gene Ther; 2015 Nov; 22(11):908-16. PubMed ID: 26133785
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy in cystic fibrosis.
Prickett M; Jain M
Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
[TBL] [Abstract][Full Text] [Related]
38. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
[TBL] [Abstract][Full Text] [Related]
39. New therapies in cystic fibrosis.
Ratjen F; Grasemann H
Curr Pharm Des; 2012; 18(5):614-27. PubMed ID: 22229570
[TBL] [Abstract][Full Text] [Related]
40. Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients.
Amaral MD
J Intern Med; 2015 Feb; 277(2):155-166. PubMed ID: 25266997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]